{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:52:18Z","timestamp":1789426338523,"version":"build-2803163510"},"reference-count":99,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cld.2018.12.007","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T01:54:15Z","timestamp":1552010055000},"page":"247-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Rheumatologic Diseases and the Liver"],"prefix":"10.1016","volume":"23","author":[{"given":"Agazi","family":"Gebreselassie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Aduli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles D.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/cmi.2016.09","article-title":"Basic liver immunology","volume":"13","author":"Gao","year":"2016","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00296-009-1010-8","article-title":"Rheumatic manifestations of hepatitis B and C and their association with viral load and fibrosis of the liver","volume":"30","author":"Aydeniz","year":"2010","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.rdc.2017.09.008","article-title":"Rheumatic manifestations in autoimmune liver disease","volume":"44","author":"Selmi","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib4","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12883-017-0818-1","article-title":"Clinical features and outcome in patients with osseomuscular type of Wilson's disease","volume":"17","author":"Yu","year":"2017","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib5","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/rheumatology\/kes392","article-title":"Idiopathic hand osteoarthritis vs haemochromatosis arthropathy--a clinical, functional and radiographic study","volume":"52","author":"Dallos","year":"2013","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib6","first-page":"148","article-title":"Obesity and osteoarthritis","volume":"37","author":"Lementowski","year":"2008","journal-title":"Am J Orthop (Belle Mead NJ)"},{"issue":"Suppl 1","key":"10.1016\/j.cld.2018.12.007_bib7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S1665-2681(19)31820-4","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)","volume":"8","author":"Bellentani","year":"2009","journal-title":"Ann Hepatol"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib8","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11926-017-0688-y","article-title":"Gout and metabolic syndrome: a tangled web","volume":"19","author":"Thottam","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.cld.2018.12.007_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-015-0601-x","article-title":"Body mass index and the risk of rheumatoid arthritis: a\u00a0systematic review and dose-response meta-analysis","volume":"17","author":"Qin","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cld.2018.12.007_bib10","doi-asserted-by":"crossref","first-page":"1423462","DOI":"10.1155\/2016\/1423462","article-title":"Diagnosis and management of cirrhosis-related osteoporosis","volume":"2016","author":"Santos","year":"2016","journal-title":"Biomed Res Int"},{"issue":"13","key":"10.1016\/j.cld.2018.12.007_bib11","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2169\/internalmedicine.52.9458","article-title":"Liver dysfunction in patients with systemic lupus erythematosus","volume":"52","author":"Takahashi","year":"2013","journal-title":"Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/00365521.2011.558114","article-title":"Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases","volume":"46","author":"Efe","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"11","key":"10.1016\/j.cld.2018.12.007_bib13","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1093\/rheumatology\/kem158","article-title":"The abdominal manifestations of the antiphospholipid syndrome","volume":"46","author":"Uthman","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib14","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/anr.1780320421","article-title":"Hepatic infarction in a patient with the lupus anticoagulant","volume":"32","author":"Mor","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0046-8177(92)90033-Y","article-title":"The liver in systemic lupus erythematosus: pathologic analysis of 52 cases and review of Japanese Autopsy Registry Data","volume":"23","author":"Matsumoto","year":"1992","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.amjms.2016.10.014","article-title":"Lupus hepatitis and autoimmune hepatitis (lupoid hepatitis)","volume":"353","author":"Adiga","year":"2017","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/ar3319","article-title":"Liver involvement in subjects with rheumatic disease","volume":"13","author":"Selmi","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/rheumatology\/36.2.210","article-title":"Histologic liver abnormalities in an autopsy series of patients with rheumatoid arthritis","volume":"36","author":"Ruderman","year":"1997","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.cld.2018.12.007_bib19","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3346\/jkms.2017.32.7.1207","article-title":"A\u00a0case of rheumatoid vasculitis involving hepatic artery in early rheumatoid arthritis","volume":"32","author":"Lee","year":"2017","journal-title":"J\u00a0Korean Med Sci"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00004836-200210000-00020","article-title":"Nodular regenerative hyperplasia in a rheumatoid arthritis patient without Felty's syndrome","volume":"35","author":"Goritsas","year":"2002","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0002-9343(82)90921-4","article-title":"Liver disease in Felty's syndrome","volume":"73","author":"Thorne","year":"1982","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib22","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1440-1746.2006.04751.x","article-title":"Development of antimitochondrial antibodies in patients with autoimmune hepatitis: art of facts or an artifact?","volume":"22","author":"Liaskos","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00296-018-4021-5","article-title":"Clinical connection between rheumatoid arthritis and liver damage","volume":"38","author":"Radovanovic-Dinic","year":"2018","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib24","first-page":"121","article-title":"Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with liver diseases","volume":"26","author":"Koga","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib25","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2018.12.007_bib26","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-2-21","article-title":"The liver is a common non-exocrine target in primary Sjogren's syndrome: a retrospective review","volume":"2","author":"Kaplan","year":"2002","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"10.1016\/j.cld.2018.12.007_bib27","first-page":"1593","article-title":"Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjogren's syndrome","volume":"33","author":"Ramos-Casals","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib28","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/0002-9610(84)90212-5","article-title":"Sclerosing cholangitis, chronic pancreatitis, and Sjogren's syndrome: a syndrome complex","volume":"147","author":"Montefusco","year":"1984","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib29","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0168-8278(94)80007-3","article-title":"Autoimmune liver disease in patients with primary Sjogren's syndrome","volume":"20","author":"Lindgren","year":"1994","journal-title":"J\u00a0Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2559.1997.d01-561.x","article-title":"Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjogren's syndrome","volume":"30","author":"Scott","year":"1997","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib31","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2017.09.002","article-title":"Gastrointestinal and hepatic disease in systemic sclerosis","volume":"44","author":"Frech","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2018.12.007_bib33","first-page":"iii36","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib34","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.clinre.2013.04.005","article-title":"Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis","volume":"37","author":"Liberal","year":"2013","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.rdc.2017.09.004","article-title":"Gastrointestinal and hepatic disease in spondyloarthritis","volume":"44","author":"Caplan","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib37","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jaad.2013.10.044","article-title":"Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study","volume":"70","author":"van der Voort","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib38","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.20305","article-title":"High frequency of cholestasis in generalized pustular psoriasis: evidence for neutrophilic involvement of the biliary tract","volume":"40","author":"Viguier","year":"2004","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib39","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.42.5.550","article-title":"Hepatic function in ankylosing spondylitis","volume":"42","author":"Robinson","year":"1983","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib40","first-page":"708","article-title":"Enthesopathy in a case of primary biliary cirrhosis with positive HLA-B27","volume":"15","author":"Kung","year":"1997","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/er.2008-0033","article-title":"Hypothesis: could excessive fructose intake and uric acid cause type 2 diabetes?","volume":"30","author":"Johnson","year":"2009","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib42","doi-asserted-by":"crossref","first-page":"e47948","DOI":"10.1371\/journal.pone.0047948","article-title":"Uric acid stimulates fructokinase and accelerates fructose metabolism in the development of fatty liver","volume":"7","author":"Lanaspa","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib43","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/hep.28403","article-title":"Drug-Induced Liver Injury Network. Febuxostat-induced acute liver injury","volume":"63","author":"Bohm","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2018.12.007_bib44","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.14309\/crj.2017.120","article-title":"Colchicine-induced hepatotoxicity","volume":"4","author":"Abbott","year":"2017","journal-title":"ACG Case Rep J"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib45","article-title":"Allopurinol-induced granulomatous hepatitis: a case report and review of literature","volume":"5","author":"Iqbal","year":"2017","journal-title":"J\u00a0Investig Med High Impact Case Rep"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0889-8553(05)70032-7","article-title":"The effects of vasculitis on the gastrointestinal tract and liver","volume":"27","author":"Bailey","year":"1998","journal-title":"Gastroenterol Clin North Am"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib47","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/01.CIR.35.6.1141","article-title":"Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases","volume":"35","author":"Nakao","year":"1967","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.cld.2018.12.007_bib48","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1093\/rheumatology\/ker278","article-title":"Gastrointestinal symptoms and granulomatous vasculitis involving the liver in giant cell arteritis: a case report and review of the literature","volume":"50","author":"Lee","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib49","first-page":"228","article-title":"Gastrointestinal manifestations of collagen-vascular diseases","volume":"6","author":"Bassel","year":"1995","journal-title":"Semin Gastrointest Dis"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib50","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/rheumatology\/27.4.258","article-title":"Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients","volume":"27","author":"Guillevin","year":"1988","journal-title":"Br J Rheumatol"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib51","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.nefro.2015.07.012","article-title":"Microscopic polyangiitis in a patient with primary biliary cirrhosis: treatment complications","volume":"36","author":"Ruiz-Ferreras","year":"2016","journal-title":"Nefrologia"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib52","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1665-2681(19)30915-9","article-title":"Autoimmune liver disorders and small-vessel vasculitis: four case reports and review of the literature","volume":"13","author":"Tovoli","year":"2013","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.cld.2018.12.007_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-218385","article-title":"Autoimmune hepatitis and eosinophilic granulomatosis with polyangiitis: a rare association","volume":"2017","author":"Lohani","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cld.2004.02.003","article-title":"Extrahepatic manifestations of chronic hepatitis B","volume":"8","author":"Han","year":"2004","journal-title":"Clin Liver Dis"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib55","first-page":"3","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection","volume":"3","author":"Cacoub","year":"2016","journal-title":"Ther Adv Infect Dis"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib56","doi-asserted-by":"crossref","first-page":"139","DOI":"10.31053\/1853.0605.v69.n3.21120","article-title":"Idiophatic inflammatory myophaties: its asociation with liver disorders","volume":"69","author":"Schneeberger","year":"2012","journal-title":"Rev Fac Cien Med Univ Nac Cordoba"},{"key":"10.1016\/j.cld.2018.12.007_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874312901206010054","article-title":"Laboratory test abnormalities are common in polymyositis and dermatomyositis and differ among clinical and demographic groups","volume":"6","author":"Volochayev","year":"2012","journal-title":"Open Rheumatol J"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib58","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15403\/jgld.2014.1121.cpa","article-title":"Primary biliary cirrhosis--autoimmune hepatitis overlap syndrome associated with dermatomyositis, autoimmune thyroiditis and antiphospholipid syndrome","volume":"24","author":"Pamfil","year":"2015","journal-title":"J\u00a0Gastrointestin Liver Dis"},{"issue":"11","key":"10.1016\/j.cld.2018.12.007_bib59","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.5692\/clinicalneurol.53.1114","article-title":"Clinical and histopathological features of myositis associated with anti-mitochondrial antibodies","volume":"53","author":"Shimizu","year":"2013","journal-title":"Rinsho Shinkeigaku"},{"issue":"9","key":"10.1016\/j.cld.2018.12.007_bib60","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00296-014-2984-4","article-title":"Dermatomyositis as a complication of interferon-alpha therapy: a case report and review of the literature","volume":"34","author":"Shiba","year":"2014","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mus.24959","article-title":"Hepatitis E-induced severe myositis","volume":"53","author":"Mengel","year":"2016","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib62","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jhep.2012.05.010","article-title":"Hepatitis E virus-induced severe myositis","volume":"57","author":"Del Bello","year":"2012","journal-title":"J\u00a0Hepatol"},{"issue":"9","key":"10.1016\/j.cld.2018.12.007_bib63","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1001\/archinte.1983.00350090199039","article-title":"Liver disease in mixed connective tissue disease","volume":"143","author":"Marshall","year":"1983","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.cld.2018.12.007_bib64","first-page":"733","article-title":"Mixed connective tissue disease associated with autoimmune hepatitis and pulmonary fibrosis","volume":"16","author":"Zold","year":"2014","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib65","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/j.ejim.2007.06.025","article-title":"Fulminant hepatitis requiring MARS and liver transplantation in a patient with Still's disease","volume":"19","author":"Taccone","year":"2008","journal-title":"Eur J Intern Med"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib66","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/RHU.0b013e3181b57199","article-title":"Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients","volume":"15","author":"Zhu","year":"2009","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib67","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib68","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00296-003-0290-7","article-title":"Fibromyalgia syndrome in patients with hepatitis C infection","volume":"23","author":"Kozanoglu","year":"2003","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib69","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s10620-014-3453-3","article-title":"Fibromyalgia symptoms and cirrhosis","volume":"60","author":"Rogal","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib70","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.gtc.2017.01.001","article-title":"IgG4-related disease and the liver","volume":"46","author":"Chen","year":"2017","journal-title":"Gastroenterol Clin North Am"},{"issue":"9","key":"10.1016\/j.cld.2018.12.007_bib71","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/art.39205","article-title":"IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients","volume":"67","author":"Wallace","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"15","key":"10.1016\/j.cld.2018.12.007_bib72","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","article-title":"IgG4-related disease: dataset of 235 consecutive patients","volume":"94","author":"Inoue","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/MPA.0000000000000325","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan in 2011","volume":"44","author":"Kanno","year":"2015","journal-title":"Pancreas"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib74","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/MPA.0b013e3182480c99","article-title":"Nationwide epidemiological survey of autoimmune pancreatitis in Japan","volume":"41","author":"Kanno","year":"2012","journal-title":"Pancreas"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib75","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/ajg.2014.223","article-title":"Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort","volume":"109","author":"Huggett","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/flgastro-2013-100315","article-title":"Extrahepatic manifestations of hepatitis C virus (HCV)","volume":"4","author":"Samuel","year":"2013","journal-title":"Frontline Gastroenterol"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib77","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2016.09.158","article-title":"Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals","volume":"15","author":"Bonacci","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.cld.2018.12.007_bib78","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis - a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 3","key":"10.1016\/j.cld.2018.12.007_bib79","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.cld.2018.12.007_bib80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1542-3565(04)00777-3","article-title":"Nonsteroidal anti-inflammatory drugs and hepatic toxicity: a systematic review of randomized controlled trials in arthritis patients","volume":"3","author":"Rostom","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S1089-3261(03)00022-9","article-title":"Hepatotoxicity associated with non-steroidal anti-inflammatory drugs","volume":"7","author":"Teoh","year":"2003","journal-title":"Clin Liver Dis"},{"issue":"4","key":"10.1016\/j.cld.2018.12.007_bib82","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/pds.755","article-title":"Prescription and non-prescription analgesic use among the US adult population: results from the third National Health and Nutrition Examination Survey (NHANES III)","volume":"12","author":"Paulose-Ram","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.cld.2018.12.007_bib83","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1185\/03007990903018279","article-title":"The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials","volume":"25","author":"Soni","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cld.2018.12.007_bib84","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jsbmb.2015.07.020","article-title":"Glucocorticoids and non-alcoholic fatty liver disease","volume":"154","author":"Woods","year":"2015","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib85","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/NRL.0000000000000029","article-title":"Methylprednisolone-induced toxic hepatitis after intravenous pulsed therapy for multiple sclerosis relapses","volume":"19","author":"Ferraro","year":"2015","journal-title":"Neurologist"},{"issue":"1","key":"10.1016\/j.cld.2018.12.007_bib86","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/j.gastro.2014.10.038","article-title":"American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Perrillo","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.cld.2018.12.007_bib87","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/FTD.0b013e31826a6306","article-title":"Old and new antirheumatic drugs and the risk of hepatotoxicity","volume":"34","author":"Anelli","year":"2012","journal-title":"Ther Drug Monit"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib88","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3899\/jrheum.110310","article-title":"Prevalence and risk factors for liver biochemical abnormalities in Canadian patients with systemic lupus erythematosus","volume":"39","author":"Huang","year":"2012","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semarthrit.2015.05.003","article-title":"Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials","volume":"45","author":"Conway","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.cld.2018.12.007_bib90","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/acr.22294","article-title":"Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record","volume":"66","author":"Schmajuk","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"26","key":"10.1016\/j.cld.2018.12.007_bib91","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.4254\/wjh.v9.i26.1092","article-title":"Risk of liver disease in methotrexate treated patients","volume":"9","author":"Conway","year":"2017","journal-title":"World J Hepatol"},{"issue":"7","key":"10.1016\/j.cld.2018.12.007_bib92","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/ard.2008.094474","volume":"68","author":"Visser","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.cld.2018.12.007_bib93","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.cld.2018.12.007_bib94","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"46","key":"10.1016\/j.cld.2018.12.007_bib95","doi-asserted-by":"crossref","first-page":"17352","DOI":"10.3748\/wjg.v20.i46.17352","article-title":"Anti-tumour necrosis factor agent and liver injury: literature review, recommendations for management","volume":"20","author":"Rossi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.cld.2018.12.007_bib96","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.cgh.2018.04.033","article-title":"Incidence of hepatitis B virus reactivation and hepatotoxicity in patients receiving long-term treatment with tumor necrosis factor antagonists","volume":"16","author":"Pauly","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2018.12.007_bib97","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/14712598.2012.646986","article-title":"Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management","volume":"12","author":"Vigano","year":"2012","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"10.1016\/j.cld.2018.12.007_bib98","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/jvh.12402","article-title":"Hepatitis B reactivation in HBsAg-negative\/HBcAb-positive patients receiving rituximab for lymphoma: a meta-analysis","volume":"22","author":"Mozessohn","year":"2015","journal-title":"J\u00a0Viral Hepat"},{"issue":"3","key":"10.1016\/j.cld.2018.12.007_bib99","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2014-206711","article-title":"A\u00a0comparison of safety profiles of tumour necrosis factor alpha inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C","volume":"74","author":"Chen","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326118301119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:58Z","timestamp":1761069418000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326118301119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":99,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1089326118301119"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.007","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rheumatologic Diseases and the Liver","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2018.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}